diethylstilbestrol has been researched along with Androgen-Independent Prostatic Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherny, N; Gabizon, A; Gips, M; Grenader, T; Plotkin, Y | 1 |
| Chahal, R; Cross, WR; Prescott, S; Sundaram, SK; Tan, K; Thygesen, H; Turo, R | 1 |
| Pomroy, FE; Sinha, AA; Wilson, MJ | 1 |
3 other study(ies) available for diethylstilbestrol and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: retrospective analysis of a single institution experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Diethylstilbestrol; Disease Progression; Estrogens, Non-Steroidal; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Pulmonary Embolism; Retrospective Studies; Treatment Outcome; Venous Thromboembolism | 2014 |
Diethylstilboestrol (1 mg) in the management of castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Diethylstilbestrol; Disease Progression; Estrogens, Non-Steroidal; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome | 2015 |
Concurrent Androgen and Estrogen Ablation and Inhibition of Steroid Biosynthetic Enzyme Treatment for Castration-resistant Prostate Cancer.
Topics: Aged; Aged, 80 and over; Androgens; Biopsy; Cell Line, Tumor; Cell Proliferation; Diethylstilbestrol; Estrogens; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Prostate; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Receptors, Estrogen | 2016 |